TOMM5 is associated with oral cancer progression: a multi-omics analysis from single-cell atlas to in vitro validation.
TOMM5 protein expression predicts immune response and drug sensitivity in oral cancer, potentially guiding treatment selection.
This diagnostic validation study examined TOMM5 is associated with oral cancer progression: a multi-omics analysis from single-cell atlas to in vitro validation. The abstract reports that High TOMM5 expression was linked to reduced immune cell infiltration and sensitivity to Paclitaxel/Vincristine.
What the study was
- Study design
- Diagnostic validation study
- Population
- Human participants
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Future Sci OA
Why it surfaced
Diagnostic validation study; directly matches Precision oncology and genomic medicine. Conservative abstract-level score 8/10.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.